Generation of mice with a conditional Foxp2 null allele.
ABSTRACT Disruptions of the human FOXP2 gene cause problems with articulation of complex speech sounds, accompanied by impairment in many aspects of language ability. The FOXP2/Foxp2 transcription factor is highly similar in humans and mice, and shows a complex conserved expression pattern, with high levels in neuronal subpopulations of the cortex, striatum, thalamus, and cerebellum. In the present study we generated mice in which loxP sites flank exons 12-14 of Foxp2; these exons encode the DNA-binding motif, a key functional domain. We demonstrate that early global Cre-mediated recombination yields a null allele, as shown by loss of the loxP-flanked exons at the RNA level and an absence of Foxp2 protein. Homozygous null mice display severe motor impairment, cerebellar abnormalities and early postnatal lethality, consistent with other Foxp2 mutants. When crossed to transgenic lines expressing Cre protein in a spatially and/or temporally controlled manner, these conditional mice will provide new insights into the contributions of Foxp2 to distinct neural circuits, and allow dissection of roles during development and in the mature brain.
- SourceAvailable from: John D Eicher[Show abstract] [Hide abstract]
ABSTRACT: Dyslexia is a common pediatric disorder that affects 5-17% of schoolchildren in the United States. It is marked by unexpected difficulties in fluent reading despite adequate intelligence, opportunity, and instruction. Classically, neuropsychologists have studied dyslexia using a variety of neurocognitive batteries to gain insight into the specific deficits and impairments in affected children. Since dyslexia is a complex genetic trait with high heritability, analyses conditioned on performance on these neurocognitive batteries have been used to try to identify associated genes. This has led to some successes in identifying contributing genes, although much of the heritability remains unexplained. Additionally, the lack of relevant human brain tissue for analysis and the challenges of modeling a uniquely human trait in animals are barriers to advancing our knowledge of the underlying pathophysiology. In vivo imaging technologies, however, present new opportunities to examine dyslexia and reading skills in a clearly relevant context in human subjects. Recent investigations have started to integrate these imaging data with genetic data in attempts to gain a more complete and complex understanding of reading processes. In addition to bridging the gap from genetic risk variant to a discernible neuroimaging phenotype and ultimately to the clinical impairments in reading performance, the use of neuroimaging phenotypes will reveal novel risk genes and variants. In this article, we briefly discuss the genetic and imaging investigations and take an in-depth look at the recent imaging-genetics investigations of dyslexia.Molecular Genetics and Metabolism 07/2013; · 2.83 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Synapse formation in the developing brain depends on the coordinated activity of synaptogenic proteins, some which have been implicated in a number of neurodevelopmental disorders. Here, we show that the sushi repeat-containing domain protein X-linked 2 (SRPX2) gene encodes a protein that promotes synaptogenesis in the cerebral cortex. In humans, SRPX2 is an epilepsy- and language-associated gene that is a target of the foxhead box protein P2 (FoxP2) transcription factor. We also show that FoxP2 modulates synapse formation through regulating SRPX2 levels, and that SRPX2 reduction impairs development of ultrasonic vocalization in mice. Our results suggest FoxP2 modulates the development of neural circuits through regulating synaptogenesis and that SRPX2 is a synaptogenic factor that plays a role in the pathogenesis of language disorders.Science 10/2013; · 31.20 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Childhood apraxia of speech (CAS) is a rare, severe, persistent pediatric motor speech disorder with associated deficits in sensorimotor, cognitive, language, learning and affective processes. Among other neurogenetic origins, CAS is the disorder segregating with a mutation in FOXP2 in a widely studied, multigenerational London family. We report the first whole-exome sequencing (WES) findings from a cohort of 10 unrelated participants, ages 3 to 19 years, with well-characterized CAS. As part of a larger study of children and youth with motor speech sound disorders, 32 participants were classified as positive for CAS on the basis of a behavioral classification marker using auditory-perceptual and acoustic methods that quantify the competence, precision and stability of a speaker's speech, prosody and voice. WES of 10 randomly selected participants was completed using the Illumina Genome Analyzer IIx Sequencing System. Image analysis, base calling, demultiplexing, read mapping, and variant calling were performed using Illumina software. Software developed in-house was used for variant annotation, prioritization and interpretation to identify those variants likely to be deleterious to neurodevelopmental substrates of speech-language development. Among potentially deleterious variants, clinically reportable findings of interest occurred on a total of five chromosomes (Chr3, Chr6, Chr7, Chr9 and Chr17), which included six genes either strongly associated with CAS (FOXP1 and CNTNAP2) or associated with disorders with phenotypes overlapping CAS (ATP13A4, CNTNAP1, KIAA0319 and SETX). A total of 8 (80%) of the 10 participants had clinically reportable variants in one or two of the six genes, with variants in ATP13A4, KIAA0319 and CNTNAP2 being the most prevalent. Similar to the results reported in emerging WES studies of other complex neurodevelopmental disorders, our findings from this first WES study of CAS are interpreted as support for heterogeneous genetic origins of this pediatric motor speech disorder with multiple genes, pathways and complex interactions. We also submit that our findings illustrate the potential use of WES for both gene identification and case-by-case clinical diagnostics in pediatric motor speech disorders.Journal of Neurodevelopmental Disorders 10/2013; 5(1):29. · 3.45 Impact Factor
Generation of Mice With a Conditional Foxp2 Null Allele
Catherine A. French,1* Matthias Groszer,1Christopher Preece,1Anne-Marie Coupe,1
Klaus Rajewsky,2and Simon E. Fisher1
1The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
2The CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts
Received 19 March 2007; Accepted 5 April 2007
Summary: Disruptions of the human FOXP2 gene cause
problems with articulation of complex speech sounds,
accompanied by impairment in many aspects of language
ability. The FOXP2/Foxp2 transcription factor is highly
similar in humans and mice, and shows a complex con-
served expression pattern, with high levels in neuronal
subpopulations of the cortex, striatum, thalamus, and cer-
ebellum. In the present study we generated mice in which
loxP sites flank exons 12–14 of Foxp2; these exons
encode the DNA-binding motif, a key functional domain.
We demonstrate that early global Cre-mediated recombi-
nation yields a null allele, as shown by loss of the loxP-
flanked exons at the RNA level and an absence of Foxp2
protein. Homozygous null mice display severe motor
impairment, cerebellar abnormalities and early postnatal
lethality, consistent with other Foxp2 mutants. When
crossed to transgenic lines expressing Cre protein in a
spatially and/or temporally controlled manner, these con-
ditional mice will provide new insights into the contribu-
tions of Foxp2 to distinct neural circuits, and allow dissec-
tion of roles during development and in the mature brain.
genesis 45:440–446, 2007. Published 2007 Wiley-Liss, Inc.y
Key words: Foxp2;
speech and language; brain development
There are now multiple examples of disruption of the
human FOXP2 gene, with affected individuals displaying
speech and language deficits of varying severity (Lai
et al., 2001; MacDermot et al., 2005; Shriberg et al.,
2006; Zeesman et al., 2006). The first example to be dis-
covered, and hence the most well studied, is that of the
KE family. A heterozygous missense mutation is inher-
ited by affected members (Lai et al., 2001), who have an
impaired ability to learn and produce the sequences of
coordinated mouth movements necessary for speech; a
condition commonly referred to as developmental verbal
dyspraxia (Vargha-Khadem et al., 2005). These problems
are accompanied by expressive and receptive deficits in
oral and written language (Watkins et al., 2002). Func-
tional neuroimaging studies have shown abnormal pat-
terns of brain activation, including underactivation of
Broca’s area, during language-based tasks (Liegeois et al.,
2003). To date, FOXP2 is the only gene clearly linked to
this aspect of neurological function, providing a unique
involved (Marcus and Fisher, 2003; Vernes et al., 2006).
The FOXP2 protein belongs to a group of transcrip-
tion factors characterized by the presence of a forkhead-
box (FOX) DNA-binding domain. FOX proteins regulate
a diverse variety of processes from early embryogenesis
through to adulthood, and have been implicated in disor-
ders of human or mouse development (Carlsson and
Mahlapuu, 2002). Several domains have been identified
in FOXP2 in addition to the characteristic DNA-binding
motif, including polyglutamine tracts, a zinc finger, a leu-
cine zipper, and an acidic C-terminal region (Wang et al.,
2003). The FOXP2 amino acid sequence is highly similar
across a number of distantly-related vertebrate species;
the human and mouse proteins are distinguished by only
three amino acid substitutions and a single-residue differ-
ence in polyglutamine-tract length (Enard et al., 2002).
Moreover, orthologues of FOXP2 show conserved
expression in equivalent brain structures in humans,
rodents, birds, reptiles, and fish, with notable similarities
in sublocalisation (Fisher and Marcus, 2006; Vargha-Kha-
dem et al., 2005). Key expression sites lie within the cor-
tex (pallium in nonmammals), striatum, thalamus, and
cerebellum. In the mammalian cortex the gene is mainly
expressed in the deepest layers, in the rat striatum it is
enriched in striosomes, while hindbrain expression is
confined to inferior olives, Purkinje cells, and deep cere-
bellar nuclei in all species studied thus far (Bonkowsky
and Chien, 2005; Ferland et al., 2003; Haesler et al.,
2004; Lai et al., 2003; Takahashi et al., 2003; Teramitsu
et al., 2004).
*Correspondence to: Simon E. Fisher, The Wellcome Trust Centre for
Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN,
Contract grant sponsors: Wellcome Trust, NIH.
yThis article is a US Government work and, as such, is in the public
domain in the United States of America.
Published online in
Wiley InterScience (www.interscience.wiley.com).
Published 2007 Wiley-Liss, Inc. genesis 45:440–446 (2007)
These data point to widely conserved functions of
FOXP2 orthologues in distributed vertebrate circuits
involved in sensory processing, sensorimotor integra-
tion, and control of skilled coordinated movements.
Analyses of primate sequence variation suggest that the
precise roles of FOXP2 may have undergone modifica-
tions during human history, perhaps in relation to
speech (Enard et al., 2002). Nevertheless, animal models
will yield crucial insights into the contributions of the
gene to the development and function of relevant neural
circuits, and how they may go awry in cases of disorder.
Gene disruption in the mouse is a highly amenable tool
for addressing this question. Given the complexities of
Foxp2 expression during embryogenesis, postnatal de-
velopment and adulthood, in both neural (Ferland et al.,
2003; Lai et al., 2003) and non-neural tissues (Shu et al.,
2001), a strategy that allows spatiotemporal control of
gene disruption is particularly valuable. Thus, in the
present study, we have generated a mouse line in which
critical exons of Foxp2 are flanked by loxP sites (floxed),
and demonstrated successful Cre-mediated disruption of
It is unfeasible to target the entire Foxp2 locus, since it
spans several hundred kilobases. Instead, we chose to
insert loxP sites around exons 12–14, which encode the
DNA-binding motif (Fig. 1). In addition to removing an
essential functional domain, loss of these exons is pre-
dicted to yield premature termination of protein transla-
tion early in exon 15, because of a frameshift. Of note,
Shu et al. previously targeted a similar region of Foxp2 in
genomic locus results in the introduction of a FLPe-Neo cassette, flanked by FRT sites (ovals), 50of exon 12, and leaves two loxP sites
(arrows) surrounding the cassette and exons 12–14. The thymidine kinase gene at the 30end of the targeting vector enables selection
against clones containing randomly integrated vector. FLPe-mediated recombination enables removal of the selection cassette, and gener-
ates the floxDneo allele. The D12–14 allele can be generated from either the floxneo or floxDneo allele by Cre-mediated recombination. PCR
genotyping primers and relevant restriction enzyme sites and probes used for Southern analysis are indicated.
Schematic representation of the Foxp2 conditional targeting strategy. Recombination of the targeting vector with the Foxp2
MICE WITH A CONDITIONAL FOXP2 NULL ALLELE
genesis DOI 10.1002/dvg
standard knockout experiments, and reported that
replacement of exons 12 and 13 by a neomycin resist-
ance cassette produced a null allele (Shu et al., 2005).
For the present study, Bruce-4 ES cells (Kontgen et al.,
1993), of C57BL/6 origin, were transfected with linear-
ized conditional targeting vector. Clones surviving
selection were screened by Southern blotting for
appropriate integration of the 50and 30loxP sites, and
the neomycin cassette (Fig. 2a). Correctly targeted
clone 1 cells were injected into C57BL/6 albino blasto-
cysts to obtain a male chimera. Breeding to C57BL/6
albino females yielded germline transmission, and
Foxp2floxneo/þheterozygotes were identified by coat
color and PCR genotyping (Fig. 2b).
We removed the neomycin resistance gene, since it is
well established that the presence of this selection cas-
sette can influence expression of the floxed gene and/or
neighboring loci (Lewandoski, 2001). The targeting con-
struct incorporates a FLPe gene, driven by the testes-spe-
cific ACE promoter, which theoretically drives ‘‘self-exci-
sion’’ of the FRT-flanked selection cassette in the testes.
However, we found no evidence that the cassette had
been removed in chimeric offspring, probably because
of insufficient levels of FLPe protein expression. We
therefore mated Foxp2floxneo/þheterozygotes to ACTB-
FLPe hemizygotes [Fig. 1(ii)], which express FLPe ubiq-
uitously under control of human b-actin regulatory
sequences (Rodriguez et al., 2000) and offspring were
genotyped by PCR (Fig 2b). Resulting Foxp2floxDneo/þ
heterozygotes were then bred to C57BL/6 wildtype ani-
mals to remove the ACTB-FLPe transgene from the
floxed strain. Mice carrying the floxDneo allele will be
used for future crosses to transgenic strains expressing
Cre recombinase in a region- and/or temporal-specific
manner [Fig. 1(iii)].
To verify functionality of the loxP sites in vivo, and to
determine if Cre-mediated excision of exons 12–14 pro-
duces a null allele, we crossed Foxp2floxneo/þmales to
Foxp2D12–14/þ;Sox2-Creþ/?females [Fig. 1(iv)]. Sox2-Cre
mice provide an efficient means for deleting loxP-flanked
sequences, particularly when the Cre transgene is car-
ried on the maternal line. In this case excision occurs
throughout the early embryo, in all offspring, irrespec-
tive of whether they receive the transgene (Hayashi
et al., 2003; Vincent and Robertson, 2003). As expected,
these crosses produced general deletion of exons 12–14
in offspring and successfully yielded Foxp2D12–14/þand
Foxp2D12–14/D12–14pups, demonstrated by PCR-based
genotyping (Fig. 2b). Quantitative real-time RT-PCR was
used to analyse Foxp2 expression in the striatal precur-
sor region of E16.5 embryos from such crosses. Three
sets of Foxp2 primers were employed from different
regions of the transcript. Foxp2D12–14/D12–14homozy-
gotes lacked the FOX domain-encoding exons – primer
pair 13/14 yielded no product in these embryos, and a
half-dosage in Foxp2D12–14/þheterozygotes (Fig. 3a). RT-
PCR assays for exons 6–7 and 16 showed reduced
expression levels in Foxp2D12–14/D12–14embryos as com-
pared to wildtype littermates, with intermediate levels
in Foxp2D12–14/þembryos. These data suggest that ei-
ysis of ES cell clone DNA. Left, SpeI-digested genomic DNA was
hybridized with a probe to exon 10 (Probe A), mapping beyond the
50end of the region included in the targeting vector. * marks an
example of a correctly targeted clone, demonstrated by the pres-
ence of a 5.6 kb fragment. The WT allele gives a 9.2 kb fragment.
Right, SwaI-digested DNA was hybridized with an intronic probe
(Probe B) mapping beyond the 30end of the region included in the
targeting vector. The WTallele gives a 22.6 kb fragment. Appropriate
integration of the 30loxP site was demonstrated by the presence of
an 8.7 kb fragment (clones 1 and 3), whereas recombination within
the loxP-flanked region yields a 15.3 kb fragment (clones 2 and 4).
(b) PCR genotyping strategy. Two PCR reactions were used to iden-
tify the four Foxp2 alleles (cf. Figure 1). The P1/P2/P4 multiplex
reaction detects WT, floxneo and floxDneo (top panel), and the P1/
P6 primer pair detects D12–14 (bottom panel).
Generation of a Foxp2 conditional allele. (a) Southern anal-
from the striatal precusor region of E16.5 embryos (error bars represent SDs). Data confirm a total loss of Foxp2 exons 13–14 in tran-
scripts from homozygous mutants, and a half-dosage of these exons in heterozygotes. Flanking exons (6–7 and 16) show reduced
expression in mutants. Expression of Foxp1, Foxp4, Gad2, and Dlx2 appears normal in mutants. (b) Western blot analysis of lysates from
the striatal precusor region of E16.5 embryos using an antibody recognizing the N-terminus of Foxp2. Reprobing with an anti-actin anti-
body demonstrates equal protein loading. (c) Pup weights (error bars represent SE of the mean). (d) Percentage of pups with both eyes
open at P15. (e) Time taken for pups to right themselves after being placed on their backs (error bars represent SE of the mean); note that
WT and heterozygote pups are able to right themselves with virtually no delay. (f) Cerebellar morphology at P22 in WT (i, ii), heterozygotes
(iii, iv), and homozygotes (v, vi). Homozygotes show reduced cerebellar size and foliation, as shown by whole brains (i, iii, v) and Nissl-
stained sagittal sections through the vermis (ii, iv, vi). All whole brain photographs were taken at the same magnification.
Global Cre-mediated deletion of exons 12–14 yields mice that are null for Foxp2. (a) Quantitative real-time RT-PCR using RNA
FRENCH ET AL.
genesis DOI 10.1002/dvg
MICE WITH A CONDITIONAL FOXP2 NULL ALLELE
ther a significant proportion of transcripts from the con-
ditional allele are unstable/degraded e.g. by nonsense
mediated mRNA decay, or genomic regulatory sequences
between exons 12–14 influence expression of Foxp2. Of
note, mutant mice that carry an early stop codon in
exon 7 of Foxp2 show comparable reductions in Foxp2
mRNA expression levels (Groszer et al., in preparation).
No changes in relative RNA expression were observed
for Foxp1, Foxp4, or other striatally expressed genes,
Gad2 (Katarova et al., 2000) and Dlx2 (Porteus et al.,
1991) at this developmental time (Fig. 3a).
Extracts from the striatal precursor region of E16.5
embroys were analysed by Western blotting using an N-
terminal Foxp2 antibody, to determine the impact of
Cre-mediated deletion at the protein level. A single band
corresponding to full-length Foxp2 was observed in
wildtype extracts and in Foxp2D12–14/þextracts at a
reduced intensity (Fig. 3b). No bands could be detected
in Foxp2D12–14/D12–14extracts; there was no evidence of
any truncated protein resulting from loss of exons 12–14
and termination of translation in exon 15 (Fig. 3b).
Homozygous Foxp2D12–14/D12–14pups have a reduced
body weight when compared with littermates, and typi-
cally die around postnatal day 21 (Fig. 3c). In addition,
they display developmental delays (Fig. 3d) and severe
motor dysfunction, including an impaired righting reflex
(Fig. 3e). Although most of the brain appears grossly nor-
mal, there is a substantial reduction in the size and folia-
tion of the cerebellum (Fig. 3f). By contrast, heterozy-
gous Foxp2D12–14/þpups display no overt abnormal-
ities—they gain weight at the same rate as their wildtype
littermates, do not show significant righting deficits, and
have normal cerebellar size and foliation (Fig. 3c–f). Phe-
notypes of these homozygous and heterozygous animals
are highly consistent with those observed in mutant
mice carrying an early stop codon in exon 7 of Foxp2
(Groszer et al., in preparation). The gross phenotype of
Foxp2D12–14/D12–14homozygotes also recapitulates that
obtained by Shu et al. for their standard targeted knock-
out of exons 12–13 (Shu et al., 2005). However, hetero-
zygotes in the Shu et al. study displayed modest develop-
mental delay and reduced rate of weight gain (Shu et al.,
2005), unlike our Foxp2D12–14/þheterozygotes, which
show no such deficits.
In conclusion, we have generated a conditional
Foxp2 allele and shown that homozygous general dele-
tion of exons 12–14 results in absence of Foxp2 pro-
tein, accompanied by developmental delays, severe
motor dysfunction, and neural abnormalities. Crossing
our floxed line with transgenic mice which express
Cre-recombinase in a spatially and/or temporally con-
trolled manner should circumvent problems associated
with early postnatal lethality and allow investigations
of adult animals. Such studies will facilitate investiga-
tions of Foxp2 function in the various tissues where it
is expressed, including brain, lung, intestine, and cardi-
ovascular system. Most importantly, our conditional
allele represents a powerful tool for dissecting the dif-
ferential contributions of Foxp2 to development and
function of distinct neural networks in the mammalian
central nervous system.
MATERIALS AND METHODS
Gene Targeting and Generation of Mutant Mice
Exon numbering for murine Foxp2 is concordant with
that found for orthologous exons in human FOXP2 (Mac-
Dermot et al., 2005), C57BL/6 DNA containing exons
11–16 of Foxp2 was cloned into the vector pEASY-FLIRT
(Casola, 2004). The resulting construct contained a loxP-
FRT-FLPe-NeoR-FRT cassette between exons 11 and 12,
with a second loxP site inserted between exons 14 and
15. Bruce-4 ES cells were cultured on a mitotically inac-
tive primary MEF feeder layer as described previously
(Torres and Kuhn, 1997). 1.2 3 107ES cells were trans-
fected by electroporation with 25 lg of ClaI-linearized
targeting construct. Colonies surviving G418 (163 lg/
mL active ingredient) and gancyclovir (2 lM) selection
were screened for targeted recombination by Southern
blot analysis. Morula-stage embryos were harvested 2.5
days post coitum from superovulated C57BL/6 albino
females (C57BL/6J-Tyrc-2J, Jackson Laboratories) and cul-
tured overnight in M16 media. The following day,
healthy blastocysts were injected with ES cells and trans-
ferred to pseudo-pregnant CD-1 females. Resulting chi-
meras were bred to C57BL/6 albino mice, to enable
germline transmission to be determined by coat color.
All regulated procedures were carried out under UK
Home Office Project Licence 30/2016.
PCR Genotyping of Embryos and Mice
Genotyping was performed using lysates prepared from
a mouse ear-punch or a small piece of embryo tail. Tis-
sue was digested in 100 lL lysis buffer (50 mM Tris-HCl
pH 8.5, 1 mM EDTA, 0.5% Tween 20, 0.5 lg/mL Protein-
ase K) for 1–2 h at 568C, followed by Proteinase K inacti-
vation at 958C for 5–10 min. Digested samples were
microcentrifuged at full speed for 5 min, and 1 lL of the
resulting supernatant was added to a 24 lL PCR mix con-
taining HotStarTaq polymerase (QIAGEN) prepared
according to the manufacturer’s protocol. The strategy
used to genotype the various Foxp2 alleles is described
in Figures 1 and 2 and used the following primers; P1: 50-
TGTCACGTGTGTAAAAAGTCATCTT-30, P2: 50-GAGCAT
GACAGTGGAATTGAATTAT-30, P4: 50-GTCCACTTGTCC
CTCACTAGTAAAA-30, P6: 50-GGATTAACTATTTCTGGA
ATGCAAA-30. The Cre and FLPe transgenes were geno-
typed using primers; Cre1s: 50-TGATGGACATGTTCAG
Flp1: 50-GTGGATCGATCCTACCCCTTGCG-30, Flp2: 50-
GGTCCAACTGCAGCCCAAGCTTCC-30, yielding fragment
sizes of ?880 and 750 bp respectively. Identical cycling
conditions were used for P1/P2/P4 and P1/P6 PCR
assays; initial denaturation (958C for 10 min), product
amplification (13 cycles at 958C for 30 s, 658C (?0.58C/
cycle) for 30 s, 728C for 45 s, followed by 25 cycles at
FRENCH ET AL.
genesis DOI 10.1002/dvg
958C for 30 s, 588C for 30 s, 728C for 40 s), and final
extension (728C for 7 min). Cre assays used the follow-
ing conditions; initial denaturation (958C for 15 min),
product amplification (35 cycles at 948C for 1 min, 558C
for 1 min, 728C for 1 min), and final extension (728C for
10 min). FLPe assays used the same conditions as Cre
assays except that the annealing temperature was raised
to 708C. DNA fragments were separated by electropho-
resis through 1.5% agarose gels.
Tissue from the striatal precursor region of E16.5
embryos was dissected into RIPA lysis buffer and dis-
rupted by sonication. Lysates were centrifuged at
10,000g for 10 min, and the protein concentrations of
the supernatants were determined by Bradford assay.
Proteins (30 lg per lane) were separated on 12% SDS-
polyacrylamide gels and transferred to PVDF mem-
branes. Membranes were blocked in 5% milk, before
overnight incubation with the primary antibody at 48C.
Goat anti-Foxp2 (N-16) polyclonal antibody (Santa Cruz
Biotechnology), and the loading control, mouse anti-
actin monoclonal antibody (Sigma), were both used at
a 1:2,000 dilution. Rabbit anti-goat (Dako) and goat
anti-mouse (BioRad) HRP-conjugated secondary anti-
bodies were applied at a 1:5,000 dilution for 1 h at
room temperature. Proteins were visualized by chemilumi-
Quantitative Real Time RT-PCR
E16.5 striatal tissue, from three brains of each genotype,
was dissected into RNAlater (Ambion), before being
snap-frozen and stored at ?808C. When required, sam-
ples were thawed and transferred to buffer RLT
(QIAGEN) with b-mercaptoethanol, and then disrupted
using a piston homogenizer. RNA was extracted using an
RNeasy kit (QIAGEN), and included an on-column
DNase digestion step. cDNA was synthesized from 2 lg
RNA using Superscript III reverse transcriptase (Invi-
trogen), according to the manufacturer’s protocol. PCR
amplification was carried out using 25 lL reaction vol-
umes with 12.5 lL of SYBR Green Supermix (BIO-RAD),
0.5 lL of each primer (10 lM) and 1 lL of cDNA. Ther-
mal cycling was performed on the iCycler iQ system
(BIO-RAD) with amplification for 50 cycles at 958C for
15 s, 608C for 30 s, and 728C for 30 s. Melting curve anal-
ysis was performed to exclude amplification of nonspe-
cific products. Relative changes in expression were cal-
culated using the 2?DDCT method (Livak and Schmittgen,
2001), using GAPDH as the internal control and the aver-
age of the wild type samples for each primer pair as the
Mice were deeply anaesthetized and transcardially per-
fused with 4% paraformaldehyde (PFA) in phosphate
buffer. Brains were removed and postfixed for a further
24 h, before being embedded in paraffin. Serial sections
were cut sagittally at 5 lM and stained with cresyl violet.
Whole brains were snap-frozen in liquid nitrogen before
being postfixed for 3 h in 4% PFA. Brains were photo-
graphed with a drop of bromophenol blue for enhanced
The authors thank Khuong Nguyen for generating the
conditional targeting construct, Stefano Casola for pro-
viding the pEASY-FLIRT universal targeting vector, Eliz-
abeth Robertson for advice and supply of the Sox2-
Cre mice, and members of the Robertson/Bikoff group
at the Wellcome Trust Centre for Human Genetics for
technical guidance. We are grateful to Carol Williams
and the staff of the British Heart Foundation Func-
tional Genetics Facility, particularly Dominika Paczoska
and Rathi Puliyadi, for help with mouse colony man-
agement and husbandry. Simon Fisher is a Royal Soci-
ety Research Fellow.
Bonkowsky JL, Chien CB. 2005. Molecular cloning and developmental
expression of foxP2 in zebrafish. Dev Dyn 234:740–746.
Carlsson P, Mahlapuu M. 2002. Forkhead transcription factors: Key
players in development and metabolism. Dev Biol 250:1–23.
Casola S. 2004. Conditional gene mutagenesis in B-lineage cells. In: Gu
H, Rajewsky K, editors. B cell protocols (Methods in molecular
biology, Vol. 271). Totowa, NJ: Humana. pp 91–110.
Enard W, Przeworski M, Fisher SE, Lai CS, Wiebe V, Kitano T, Monaco
AP, Paabo S. 2002. Molecular evolution of FOXP2, a gene involved
in speech and language. Nature 418:869–872.
Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA. 2003. Char-
acterization of Foxp2 and Foxp1 mRNA and protein in the devel-
oping and mature brain. J Comp Neurol 460:266–279.
Fisher SE, Marcus GF. 2006. The eloquent ape: Genes, brains and the
evolution of language. Nat Rev Genet 7:9–20.
Haesler S, Wada K, Nshdejan A, Morrisey EE, Lints T, Jarvis ED, Scharff
C. 2004. FoxP2 expression in avian vocal learners and non-learn-
ers. J Neurosci 24:3164–3175.
Hayashi S, Tenzen T, McMahon AP. 2003. Maternal inheritance of Cre
activity in a Sox2Cre deleter strain. Genesis 37:51–53.
Katarova Z, Sekerkova G, Prodan S, Mugnaini E, Szabo G. 2000. Do-
main-restricted expression of two glutamic acid decarboxylase
genes in midgestation mouse embryos. J Comp Neurol 424:607–
Kontgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H. 1993. Tar-
geted disruption of the MHC class II Aa gene in C57BL/6 mice. Int
Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. 2001. A fork-
head-domain gene is mutated in a severe speech and language dis-
order. Nature 413:519–523.
Lai CS, Gerrelli D, Monaco AP, Fisher SE, Copp AJ. 2003. FOXP2 expres-
sion during brain development coincides with adult sites of pa-
thology in a severe speech and language disorder. Brain 126:2455–
Lewandoski M. 2001. Conditional control of gene expression in the
mouse. Nat Rev Genet 2:743–755.
Liegeois F, Baldeweg T, Connelly A, Gadian DG, Mishkin M, Vargha-Kha-
dem F. 2003. Language fMRI abnormalities associated with FOXP2
gene mutation. Nat Neurosci 6:1230–1237.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-DD C(T)) method.
MICE WITH A CONDITIONAL FOXP2 NULL ALLELE
genesis DOI 10.1002/dvg
MacDermot KD, Bonora E, Sykes N, Coupe AM, Lai CS, Vernes SC, Var-
gha-Khadem F, McKenzie F, Smith RL, Monaco AP, Fisher SE. 2005.
Identification of FOXP2 truncation as a novel cause of develop-
mental speech and language deficits. Am J Hum Genet 76:1074–
Marcus GF, Fisher SE. 2003. FOXP2 in focus: What can genes tell us
about speech and language? Trends Cogn Sci 7:257–262.
Porteus MH, Bulfone A, Ciaranello RD, Rubenstein JL. 1991. Isolation
and characterization of a novel cDNA clone encoding a homeodo-
main that is developmentally regulated in the ventral forebrain.
Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R,
Stewart AF, Dymecki SM. 2000. High-efficiency deleter mice show
that FLPe is an alternative to Cre-loxP. Nat Genet 25:139–140.
Shriberg LD, Ballard KJ, Tomblin JB, Duffy JR, Odell KH, Williams CA.
2006. Speech, prosody, and voice characteristics of a mother and
daughter with a 7;13 translocation affecting FOXP2. J Speech Lang
Hear Res 49:500–525.
Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, Elder GA, Schmeidler J, De
Gasperi R, Sosa MA, Rabidou D, Santucci AC, Perl D, Morrisey E,
Buxbaum JD. 2005. Altered ultrasonic vocalization in mice with a
disruption in the Foxp2 gene. Proc Natl Acad Sci USA 102:9643–
Shu W, Yang H, Zhang L, Lu MM, Morrisey EE. 2001. Characterization
of a new subfamily of winged-helix/forkhead (Fox) genes that are
expressed in the lung and act as transcriptional repressors. J Biol
Takahashi K, Liu FC, Hirokawa K, Takahashi H. 2003. Expression of
Foxp2, a gene involved in speech and language, in the developing
and adult striatum. J Neurosci Res 73:61–72.
Teramitsu I, Kudo LC, London SE, Geschwind DH, White SA. 2004. Par-
allel FoxP1 and FoxP2 expression in songbird and human brain
predicts functional interaction. J Neurosci 24:3152–3163.
Torres R, Kuhn R. 1997. Laboratory protocols for conditional gene tar-
geting. Oxford: Oxford University Press. 167 p.
Vargha-Khadem F, Gadian DG, Copp A, Mishkin M. 2005. FOXP2 and the
neuroanatomy of speech and language. Nat Rev Neurosci 6:131–138.
Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, Bird
LE, Davies KE, Fisher SE. 2006. Functional genetic analysis of muta-
tions implicated in a human speech and language disorder. Hum
Mol Genet 15:3154–3167.
Vincent SD, Robertson EJ. 2003. Highly efficient transgene-independent
recombination directed by a maternally derived SOX2CRE trans-
gene. Genesis 37:54–56.
Wang B, Lin D, Li C, Tucker P. 2003. Multiple domains define the
expression and regulatory properties of Foxp1 forkhead transcrip-
tional repressors. J Biol Chem 278:24259–24268.
Watkins KE, Dronkers NF, Vargha-Khadem F. 2002. Behavioural analysis
of an inherited speech and language disorder: Comparison with
acquired aphasia. Brain 125:452–464.
Zeesman S, Nowaczyk MJ, Teshima I, Roberts W, Cardy JO, Brian J, Sen-
man L, Feuk L, Osborne LR, Scherer SW. 2006. Speech and lan-
guage impairment and oromotor dyspraxia due to deletion of
7q31 that involves FOXP2. Am J Med Genet A 140:509–514.
FRENCH ET AL.
genesis DOI 10.1002/dvg